SRD5A3 and urinary bladder cancer: Results showed that SRD5A3 exhibited a higher expression at the mRNA level in the tumor tissues of 30 bladder cancer patients than the matched adjacent non-tumor bladder tissues (Fig. 1C), so did at the protein level (Fig. 1D).